LEN vs RDNT · rev $34.19B vs rev $2.04B
LEN (LEN) versus RadNet Inc (RDNT) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
RadNet Inc (RDNT) is a diagnostics & research company listed on NASDAQ.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported RDNT revenue for 2025-12-31 was $2.04B. Net income was -$18.7M. Revenue was up 11.5% from 2024-12-31 to 2025-12-31. RDNT currently screens at market cap $4.15B.
LEN currently screens at market cap $0. RDNT currently screens at market cap $4.15B.
Not investment advice. Open the LEN and RDNT stock pages for the full models.
Not investment advice.